AGGRESSIVE FIBROMATOSIS

Clinical trials for AGGRESSIVE FIBROMATOSIS explained in plain language.

Never miss a new study

Get alerted when new AGGRESSIVE FIBROMATOSIS trials appear

Sign up with your email to follow new studies for AGGRESSIVE FIBROMATOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2

New drug tested to protect fertility in women with rare tumors

Disease control Recruiting now

This study tests the drug nirogacestat in 50 premenopausal women with desmoid tumors (a type of non-cancerous but aggressive growth). The main goal is to see if the drug affects ovarian function, such as menstrual periods and hormone levels. Participants take nirogacestat orally,…

Matched conditions: AGGRESSIVE FIBROMATOSIS

Phase: PHASE4 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC

AGGRESSIVE FIBROMATOSIS

Get alerted when new AGGRESSIVE FIBROMATOSIS trials appear

New drug tested to protect fertility in women with rare tumors